Regulatory Landscape for Raw Materials: CMC Considerations
ISPE
AUGUST 30, 2022
During the pandemic, the pharmaceutical industry faced challenges in the production of COVID-19 therapeutics and vaccines to meet global demand, as well as mitigation of drug shortages for non-COVID-19-related products, without compromising product quality or patient safety. You may unsubscribe from these ISPE communications at any time.
52 
Let's personalize your content